Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine effects in chronic heart failure by sST2 level
ChiCTR1800017748Phase 4Not yet recruiting
- Sponsor
- Second Affiliated Hospital of Kunming Medical University
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of trimetazidine in chronic heart failure (CHF) (2 cohorts), sponsored by Second Affiliated Hospital of Kunming Medical University. Primary endpoints: Ejection fraction and 6-minute walk distance. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
trimetazidine
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ChiCTR1800017748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017748.